About Walter Bushnell Pharmaceuticals Private Limited
Data last updated:
Walter Bushnell Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the contract-based services segment of the business services sector. It was incorporated on 09 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51100PB2004PTC053433. Its GSTIN is 07AABCI3158D1ZW (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as I S Ferro Sales Private Limited. It is led by directors Surendra Kumar Jangir and Satish Kumar Murgai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 157 First Floor Industrial Focal Point Phase – 7, Mohali, Punjab, India – 160055.
The company has about 64 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Walter Bushnell.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website walterbushnell.com.
Company details
CIN history
Walter Bushnell Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51100PB2004PTC053433, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100PB2004PTC053433 | Current |
| U51909DL2004PTC131144 | Previous |
| U51100DL2004PTC131144 | Previous |
Contact details
Walter Bushnell Pharmaceuticals Private Limited's registered office is in Mohali, Punjab. Its website is walterbushnell.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressC – 157 First Floor Industrial Focal Point Phase – 7, Mohali, Punjab, India – 160055
- IndustryBusiness Services, Contractual Work, Wholesale
To see the full contact details of Walter Bushnell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Walter Bushnell Pharmaceuticals operates one associated brand: Walter Bushnell. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops pharmaceutical products, drug delivery systems, and conducts clinical research for better health outcomes. | walterbushnell.com |
Financials of Walter Bushnell Pharmaceuticals Private Limited
FY 2025 filings availableWalter Bushnell Pharmaceuticals Private Limited reported revenue of ₹7,280 (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 4% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Walter Bushnell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Walter Bushnell Pharmaceuticals Private Limited
Walter Bushnell Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra Kumar Jangir Also directs: Bqube Enterprises LLP, Apeejay Stya Publishing Pvt. Ltd, Medimpex Pharmaceuticals Private Limited and 5 more | Director | 06 Feb 2017 | 9 Years 8 Months | Current |
| Satish Kumar Murgai Also directs: Walter Bushnell Pure Medilife Private Limited, Pomander Cosmetics Private Limited, Pabsco Babycare Private Limited and 5 more | Director | 06 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Walter Bushnell Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaceuticals and Chemicals Travancore Pvt Ltd | ₹7,723 (FY 2024) | -99.0% | Thiruvananthapuram, Kerala, India | |||
| Canris Pharma India Private Limited | ₹7,573 (FY 2020) | -98.0% | Bangalore, Karnataka, India | |||
| Loban Pharmaceuticals Private Limited | ₹7,500 (FY 2025) | -98.0% | Zirakpur, Punjab, India | |||
| Heartkort Pharmaceuticals Private Limited | ₹7,498 (FY 2024) | Gokalgarh, Haryana, India | ||||
| Alrioz Pharmaceuticals Private Limited | ₹7,398 (FY 2025) | -90.0% | Kolkata, West Bengal, India | |||
| Walter Bushnell Pharmaceuticals Private Limitedthis company | ₹7,280 (FY 2024) | -4.0% | 64 | Mohali, Punjab, India | ||
| Bewell Pharmaceuticals Pvt Ltd | ₹7,217 (FY 2025) | Kolkata, West Bengal, India | ||||
| Ambesten Pharmaceuticals Private Limited | ₹7,196 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Suman and Sons Pharmaceuticals Private Limited | ₹7,170 (FY 2024) | -99.0% | Gaya, Bihar, India | |||
| Panvila Pharmaceuticals Private Limited | ₹7,135 (FY 2025) | -97.0% | Thane, Maharashtra, India | |||
| Manglamurti Medicare Private Limited | ₹7,008 (FY 2024) | -100.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Walter Bushnell Pharmaceuticals Private Limited, buy the company report.
Auditor
Walter Bushnell Pharmaceuticals Private Limited is audited by G K NIGAM & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G K NIGAM & ASSOCIATES | FY 2019 | 004972N |
Shareholding
The shareholding of Walter Bushnell Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Walter Bushnell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Walter Bushnell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Walter Bushnell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Walter Bushnell Pharmaceuticals Private Limited has a workforce of 64 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Walter Bushnell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCI3158D1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Walter Bushnell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Walter Bushnell Pharmaceuticals Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Satish Kumar Murgai ceased to be Additional Director on 29 Sep 2017.
Frequently asked questions
Walter Bushnell Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in contractual work, within the business services industry. It was incorporated on 09 December 2004 (22+ years old) and is registered under CIN U51100PB2004PTC053433.
Walter Bushnell Pharmaceuticals has 2 current directors:
- Surendra Kumar Jangir - Director
- Satish Kumar Murgai - Director
The latest financial statements of Walter Bushnell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Walter Bushnell Pharmaceuticals is 07AABCI3158D1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of Walter Bushnell Pharmaceuticals is U51100PB2004PTC053433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Walter Bushnell Pharmaceuticals was incorporated on 09 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Walter Bushnell Pharmaceuticals by revenue are Pharmaceuticals and Chemicals Travancore Pvt Ltd, Canris Pharma India Private Limited, Loban Pharmaceuticals Private Limited, Heartkort Pharmaceuticals Private Limited, Alrioz Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Satish Kumar Murgai ceased to be Additional Director on 29 Sep 2017. Ajay Grover ceased to be Director on 06 Feb 2017. Rajesh Ramawatar Sharma ceased to be Director on 06 Feb 2017. Walter Bushnell Pharmaceuticals has 8 board changes on record in total.
Walter Bushnell Pharmaceuticals can be reached through the website walterbushnell.com. Its registered office is in Mohali, Punjab, India.
The registered office of Walter Bushnell Pharmaceuticals is at C – 157 First Floor Industrial Focal Point Phase – 7, Mohali, Punjab, India – 160055.
Walter Bushnell Pharmaceuticals operates in the business services industry, in the contractual work segment.